Breaking News
Inside the Fight ff MI6 and CIA Proxies Over Who Is To Lead Ukraine
The Real Elites vs. The Ruling Elites
The State Spins a New Idea for Recruiting in an Age of War
Woke Nike Booted from S&P 100 as Stock Crashes on Dismal Sales
Top Tech News
Floating data center would provide water and electricity to 32,000 homes
OpenAI Cuts Off Elon's Cursor, Humanity's First Star Probe, and Trump's Nuclear Mars Shi
Eating pollution? Plastic-to-cookie technology raises safety, environmental concerns
Ford's $30,000 Fathom EV Truck Appears More Conventional Than Expected
Berlin-based artist Simon Weckert explored that idea with Digital Camouflage...
Tether expands tokenization business into Saudi Arabia, starting with real estate
Ukraine is facing a new problem in its war with Russia:
It charges more than it discharges while driving
Dataminr AI tech to go live on NATO Maven system: CEO 
The Most Dangerous Interview Ever Recorded? PART 2 
Tumor-Destroying Sound Waves Treatment Coming to a Hospital Near You For Liver Cancer
Known as "histotripsy," the method and machinery have already been tested successfully in animals and humans, and has just been approved for use by the FDA.
HistoSonics is a company founded in 2009 to create an ultrasound device that both screens for tumors and administers histotripsy. It was born from the efforts of scientists at the University of Michigan who co-founded the firm.
"Histotripsy is an exciting new technology that, although it is in early stages of clinical use, may provide a noninvasive treatment option for patients with liver cancer. Hopefully it can be combined with systemic therapies for a synergistic therapeutic effect," said Mishal Mendiratta-Lala, professor of radiology with Michigan Medicine.
Mendiratta-Lala was the principal investigator of an FDA human trial started in 2021 which confirmed that HistoSonic's device, called Edison, can destroy cancer tumors.